Back

Dissecting the Epigenomic Differences between Smoking and Nicotine Dependence in a Veteran Cohort

Nagamatsu, S. T.; Pietrzak, R. H.; Xu, K.; Krystal, J. H.; Gelernter, J.; Montalvo-Ortiz, J. L.

2021-09-27 psychiatry and clinical psychology
10.1101/2021.09.24.21264038
Show abstract

BackgroundSmoking is a serious public health issue linked to more than 8 million deaths per year worldwide. It also may lead to nicotine dependence (ND). Smoking can induce long-lasting epigenetic changes. Although epigenetic alterations related to tobacco smoke have been largely studied, few works have investigated ND and its interaction with smoking status (SS). ObjectiveWe investigated the peripheral epigenomic profile of SS and ND in a U.S. male veteran cohort. MethodsDNA from saliva was collected from 1,135 European American (EA) male U.S. military veterans. DNAm was assessed using the Illumina Infinium Human MethylationEPIC BeadChip array. SS was evaluated as: current smokers (n=137; 12.1%) and non-current smokers (never and former smokers; n=998; 87.9%). ND was assessed using the Fagerstrom Test for Nicotine Dependence (FTND). EWAS and co-methylation analyses were conducted for SS and ND. ResultsA total of 450 and 22 genome-wide significant differentially methylated sites (DMS) were associated with SS and ND, respectively (fifteen overlapped sites). We identified 97 DMS (43 genes) in SS-EWAS previously reported in the literature, including AHRR, and F2RL3 genes (p-value range: 1.95x10-83 to 4.5x10-33). ND novel DMS mapped to NEUROG1, ANPEP, and SLC29A1. Co-methylation analysis identified 386 modules (11 SS-related and 19 ND-related). SS-related modules showed enrichment for alcoholism, chemokine signaling pathway, and neurogenesis; while ND-related modules were enriched for cellular adhesion, and nicotine addiction. ConclusionsThis study confirms previous findings and identifies novel and -potentially specific - epigenetic signatures for SS and ND in a sample of EA male veterans.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Addiction Biology
based on 13 papers
Top 0.1%
15.6%
2
Translational Psychiatry
based on 94 papers
Top 2%
10.3%
3
PLOS ONE
based on 1737 papers
Top 57%
7.7%
4
Molecular Psychiatry
based on 84 papers
Top 0.7%
7.7%
5
Scientific Reports
based on 701 papers
Top 33%
5.4%
6
Nature Communications
based on 483 papers
Top 20%
3.0%
7
Psychoneuroendocrinology
based on 12 papers
Top 0.1%
2.9%
50% of probability mass above
8
Neuropsychopharmacology
based on 29 papers
Top 1%
2.9%
9
Biological Psychiatry
based on 36 papers
Top 3%
2.5%
10
Clinical Epigenetics
based on 21 papers
Top 0.5%
2.5%
11
JAMA Psychiatry
based on 11 papers
Top 0.1%
2.4%
12
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
based on 27 papers
Top 2%
1.8%
13
Frontiers in Psychiatry
based on 56 papers
Top 6%
1.3%
14
Frontiers in Genetics
based on 32 papers
Top 3%
1.3%
15
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
based on 15 papers
Top 0.8%
1.3%
16
Biological Psychiatry Global Open Science
based on 23 papers
Top 2%
1.3%
17
Psychiatry Research
based on 33 papers
Top 4%
1.3%
18
Drug and Alcohol Dependence
based on 21 papers
Top 1%
1.2%
19
Brain, Behavior, and Immunity
based on 35 papers
Top 3%
1.2%
20
European Neuropsychopharmacology
based on 11 papers
Top 1%
1.2%
21
BMC Medicine
based on 155 papers
Top 21%
0.8%
22
American Journal of Psychiatry
based on 14 papers
Top 2%
0.8%
23
Journal of Psychiatric Research
based on 22 papers
Top 3%
0.8%
24
Cells
based on 14 papers
Top 2%
0.7%
25
Neuroscience & Biobehavioral Reviews
based on 19 papers
Top 4%
0.7%
26
Acta Neuropsychiatrica
based on 11 papers
Top 2%
0.7%
27
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
based on 28 papers
Top 3%
0.7%
28
PLOS Medicine
based on 95 papers
Top 17%
0.7%
29
Psychological Medicine
based on 52 papers
Top 7%
0.7%
30
Nature Medicine
based on 88 papers
Top 19%
0.7%